Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will present ...

Q2 2025 Earnings Call Transcript July 31, 2025 Operator: Good afternoon, and welcome to TransMedics Second Quarter 2025 ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

TransMedics posted strong Q2 results with solid growth and improving margins, while heart and lung programs offer key upside.

Medical experts conduct several tests to assess the health of the donor’s organs and other critical health details ...

Findings from St. Jude Children's Research Hospital demonstrate that virtual memory T cells, a specialized group of immune cells, provide nonspecific immunity for infants early in life.

Dramatic breakthroughs in medical research in recent years have made it possible for millions of Americans to live longer and ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...

This August, for the first time, the UAE will send a national squad of transplant recipients and living donors to the World Transplant Games under Hayat, the country’s organ donation programme.